|
Volumn 20, Issue 19-20, 2002, Pages 2618-2622
|
Clinical and serological studies on CAM-70 live attenuated measles vaccine: An 18-year survey at a pediatric clinic in Japan
|
Author keywords
Breakthrough measles; Measles vaccine; Side effects
|
Indexed keywords
LIVE VACCINE;
MEASLES VACCINE;
VIRUS ANTIBODY;
CHORIOALLANTONIC MEMBRANE 70;
MEASLES ANTIBODY;
UNCLASSIFIED DRUG;
ADOLESCENT;
ARTICLE;
BLOOD;
CHILD;
FEMALE;
HUMAN;
IMMUNOLOGY;
INFANT;
JAPAN;
MALE;
PRESCHOOL CHILD;
QUESTIONNAIRE;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
FEVER;
FOLLOW UP;
INCIDENCE;
MEASLES;
MEASLES VACCINATION;
PRIORITY JOURNAL;
SEROCONVERSION;
TREATMENT OUTCOME;
ADOLESCENT;
ANTIBODIES, VIRAL;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
INFANT;
JAPAN;
MALE;
MEASLES VACCINE;
QUESTIONNAIRES;
VACCINES, ATTENUATED;
HUMAN;
|
EID: 0037035876
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(02)00156-1 Document Type: Article |
Times cited : (3)
|
References (27)
|